| Schedule of revenues and net income from operations |
| Schedule of revenues and net income from operations | |
| |
|
| | |
June 30, 2026 | |
December 31, 2025 |
| Asset: | |
| | | |
| | |
| Healthcare | |
$ | 29,304,827 | | |
$ | 27,349,522 | |
| Real Estate | |
| 536,236 | | |
| 540,522 | |
| Corporate, administration and other | |
| 839,774 | | |
| 1,196,901 | |
| Consolidated assets | |
$ | 30,680,837 | | |
$ | 29,086,945 | |
| | |
Three Months Ended June 30, |
| | |
2026 | |
2025 |
| Revenues: | |
| |
|
| Healthcare | |
$ | 2,159,557 | | |
$ | 2,789,007 | |
| Real Estate | |
| – | | |
| – | |
| Consolidated revenues | |
$ | 2,159,557 | | |
$ | 2,789,007 | |
| | |
| | | |
| | |
| Cost of sales: | |
| | | |
| | |
| Healthcare | |
$ | 977,242 | | |
$ | 1,093,748 | |
| Real Estate | |
| – | | |
| – | |
| Consolidated cost of sales | |
$ | 977,242 | | |
$ | 1,093,748 | |
| | |
| | | |
| | |
| Operating Expenses: | |
| | | |
| | |
| Healthcare | |
| | | |
| | |
| Depreciation expense | |
$ | 253 | | |
$ | 763 | |
| Selling, general and administrative | |
| 201,663 | | |
| 217,453 | |
| Total Healthcare | |
| 201,916 | | |
| 218,216 | |
| Real Estate | |
| 2,133 | | |
| 18,350 | |
| Corporate, administration and other expenses (a) | |
| 1,522,909 | | |
| 849,016 | |
| Consolidated operating expenses | |
$ | 1,726,958 | | |
$ | 1,085,582 | |
| | |
| | | |
| | |
| (Loss) Income from operations from subsidiaries: | |
| | | |
| | |
| Healthcare | |
$ | 980,399 | | |
$ | 1,477,043 | |
| Real Estate | |
| (2,133 | ) | |
| (18,350 | ) |
| Income from operations from subsidiaries | |
| 978,266 | | |
| 1,458,693 | |
| Loss from operations from Cardiff Lexington | |
| (1,522,909 | ) | |
| (849,016 | ) |
| Total (loss) income from operations | |
$ | (544,643 | ) | |
$ | 609,677 | |
| | |
| | | |
| | |
| (Loss) Income before taxes | |
| | | |
| | |
| Healthcare | |
$ | 980,399 | | |
$ | 1,477,043 | |
| Real Estate | |
| (2,133 | ) | |
| (18,350 | ) |
| Corporate, administration and other non-operating expenses (b) | |
| (3,457,172 | ) | |
| (2,685,088 | ) |
| Consolidated loss from continuing operations | |
$ | (2,478,906 | ) | |
$ | (1,226,395 | ) |
| | |
| |
|
| | |
Six Months Ended June 30, |
| | |
2026 | |
2025 |
| Revenues: | |
| |
|
| Healthcare | |
$ | 4,381,837 | | |
$ | 5,704,574 | |
| Real Estate | |
| – | | |
| – | |
| Consolidated revenues | |
$ | 4,381,837 | | |
$ | 5,704,574 | |
| | |
| | | |
| | |
| Cost of sales: | |
| | | |
| | |
| Healthcare | |
$ | 1,881,467 | | |
$ | 2,168,782 | |
| Real Estate | |
| – | | |
| – | |
| Consolidated cost of sales | |
$ | 1,881,467 | | |
$ | 2,168,782 | |
| | |
| | | |
| | |
| Operating Expenses: | |
| | | |
| | |
| Healthcare | |
| | | |
| | |
| Depreciation expense | |
$ | 846 | | |
$ | 4,128 | |
| Loss on disposal of fixed assets | |
| – | | |
| 12,593 | |
| Selling, general and administrative | |
| 403,110 | | |
| 587,689 | |
| Total Healthcare | |
| 403,956 | | |
| 604,410 | |
| Real Estate | |
| 4,286 | | |
| 29,118 | |
| Corporate, administration and other expenses (a) | |
| 3,147,930 | | |
| 1,748,653 | |
| Consolidated operating expenses | |
$ | 3,556,172 | | |
$ | 2,382,181 | |
| | |
| | | |
| | |
| (Loss) Income from operations from subsidiaries: | |
| | | |
| | |
| Healthcare | |
$ | 2,096,414 | | |
$ | 2,931,382 | |
| Real Estate | |
| (4,286 | ) | |
| (29,118 | ) |
| Income from operations from subsidiaries | |
| 2,092,128 | | |
| 2,902,264 | |
| Loss from operations from Cardiff Lexington | |
| (3,147,930 | ) | |
| (1,748,653 | ) |
| Total (loss) income from operations | |
$ | (1,055,802 | ) | |
$ | 1,153,611 | |
| | |
| | | |
| | |
| (Loss) Income before taxes | |
| | | |
| | |
| Healthcare | |
$ | 2,096,414 | | |
$ | 2,929,785 | |
| Real Estate | |
| (4,286 | ) | |
| (29,118 | ) |
| Corporate, administration and other non-operating expenses (b) | |
| (7,663,108 | ) | |
| (4,577,839 | ) |
| Consolidated loss from continuing operations | |
$ | (5,570,980 | ) | |
$ | (1,677,172 | ) |
| (a) |
Corporate, administration and other operating expenses includes payroll, management fees, stock compensation, legal fees, accounting fees and public company/investor relations fees. |
| |
|
| (b) |
Corporate, administration and other non-operating expenses includes corporate selling, general and administrative expenses such as noted above as well as interest, amortization of notes payable discount and gain on settlement of debt. |
|